Stem Cell Mobilization Chemotherapy with Gemcitabine Is Effective and Safe in Myeloma Patients with Bortezomib Induced Neurotoxicity
Beatrice U. Mueller, Thomas Pabst(University Hospital of Bern), Katja Seipel(University of Bern), Sandra Keller(University Hospital of Bern), Behrouz Mansouri Taleghani(University of Bern)
Cited by 2
Related Papers
Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)
|Journal of Clinical Oncology|2004|300
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
|Leukemia|2014|172
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results
|Blood|2007|157
Patient blood management (PBM) in pregnancy and childbirth: literature review and expert opinion
|Archives of Gynecology and Obstetrics|2019|96
Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia
|The American Journal of Medicine|2003|72